Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Recruiting now

Conditions studied: Non Small Cell Lung Cancer

In brief

ctDNALung-Detect is an investigator-initiated single arm, multi-institution study designed to assess the ctDNA detection rate and its association with Relapse Free Survival (RFS) in operable stage T1-T4 (T3,T4 multifocal) N0M0 non-small cell lung cancer (NSCLC) patients.

Key facts

Study ID
NCT05254782
Run by
University Health Network, Toronto
People needed
360
Starts
2021-07-06
Expected to finish
2028-03-31
Last updated by the study team
2026-06-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.